Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1997 1
2001 2
2002 3
2003 1
2004 6
2005 6
2006 11
2007 4
2008 12
2009 12
2010 2
2011 16
2012 10
2013 8
2014 4
2015 10
2016 10
2017 20
2018 9
2019 8
2020 23
2021 12
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

180 results
Results by year
Filters applied: . Clear all
Page 1
Irritable bowel syndrome and gut microbiota.
Canakis A, Haroon M, Weber HC. Canakis A, et al. Curr Opin Endocrinol Diabetes Obes. 2020 Feb;27(1):28-35. doi: 10.1097/MED.0000000000000523. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 31789724 Review.
PURPOSE OF REVIEW: To provide an overview of recent studies exploring the gut microbiota in pathogenesis and treatment of irritable bowel syndrome (IBS). RECENT FINDINGS: Primary bacterial gut disturbances have been linked to the development and severity of I …
PURPOSE OF REVIEW: To provide an overview of recent studies exploring the gut microbiota in pathogenesis and treatment of irritable
Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P. Pinto-Sanchez MI, et al. Gastroenterology. 2017 Aug;153(2):448-459.e8. doi: 10.1053/j.gastro.2017.05.003. Epub 2017 May 5. Gastroenterology. 2017. PMID: 28483500 Free article. Clinical Trial.
BACKGROUND & AIMS: Probiotics can reduce symptoms of irritable bowel syndrome (IBS), but little is known about their effects on psychiatric comorbidities. ...
BACKGROUND & AIMS: Probiotics can reduce symptoms of irritable bowel syndrome (IBS), but little is known about thei …
Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
Chlebicz-Wójcik A, Śliżewska K. Chlebicz-Wójcik A, et al. Biomolecules. 2021 Aug 4;11(8):1154. doi: 10.3390/biom11081154. Biomolecules. 2021. PMID: 34439821 Free PMC article. Review.
Irritable bowel syndrome is not a life-threatening disease, yet it significantly affects the quality of life and contributes to economic loss. ...The aim of this review was to summarize findings on the usefulness of probiotics, prebiotics, and synbiotics in t
Irritable bowel syndrome is not a life-threatening disease, yet it significantly affects the quality of life and contri
Gut Microbiota and Chronic Constipation: A Review and Update.
Ohkusa T, Koido S, Nishikawa Y, Sato N. Ohkusa T, et al. Front Med (Lausanne). 2019 Feb 12;6:19. doi: 10.3389/fmed.2019.00019. eCollection 2019. Front Med (Lausanne). 2019. PMID: 30809523 Free PMC article. Review.
Background: Chronic constipation, including functional constipation and constipation-type irritable bowel syndrome, is a prevalent, multifactorial gastrointestinal disorder, and its etiology and pathophysiology remain poorly understood. ...Methods: PubMed sea …
Background: Chronic constipation, including functional constipation and constipation-type irritable bowel syndrome, is …
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.
Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. Pittayanon R, et al. Gastroenterology. 2019 Jul;157(1):97-108. doi: 10.1053/j.gastro.2019.03.049. Epub 2019 Mar 30. Gastroenterology. 2019. PMID: 30940523
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is common but difficult to treat. Altering the gut microbiota has been proposed as a strategy for treatment of IBS, but the association between the gut microbiome and IBS symptoms has not been well establi …
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is common but difficult to treat. Altering the gut microbiota has …
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, Scholz M, Tuohy KM, Lindsay JO, Irving PM, Whelan K. Staudacher HM, et al. Gastroenterology. 2017 Oct;153(4):936-947. doi: 10.1053/j.gastro.2017.06.010. Epub 2017 Jun 15. Gastroenterology. 2017. PMID: 28625832 Clinical Trial.
BACKGROUND & AIMS: Dietary restriction of fermentable carbohydrates (a low FODMAP diet) has been reported to reduce symptoms in some patients with irritable bowel syndrome (IBS). We performed a randomized, placebo-controlled study to determine its effects …
BACKGROUND & AIMS: Dietary restriction of fermentable carbohydrates (a low FODMAP diet) has been reported to reduce symptoms in some pat …
Bifidobacteria and Their Health-Promoting Effects.
Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Hidalgo-Cantabrana C, et al. Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.BAD-0010-2016. Microbiol Spectr. 2017. PMID: 28643627 Free article. Review.
Bifidobacteria are members of the intestinal microbiota of mammals and other animals, and some strains are able to exert health-promoting effects. The genus Bifidobacterium belongs to the Actinobacteria phylum. Firmicutes, Bacteroidetes, and Actinobacteria constitut …
Bifidobacteria are members of the intestinal microbiota of mammals and other animals, and some strains are able to exert health-promoting ef …
The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kanarek E, Sowińska A, Cukrowska B. Skrzydło-Radomańska B, et al. Nutrients. 2021 Feb 26;13(3):756. doi: 10.3390/nu13030756. Nutrients. 2021. PMID: 33652763 Free PMC article. Clinical Trial.
The aim of this randomized double-blind placebo-controlled study was to evaluate the effectiveness and safety of multi-strain probiotic in adults with diarrhea-predominant irritable bowel syndrome (IBS-D). The patients were randomized to receive a mixture of …
The aim of this randomized double-blind placebo-controlled study was to evaluate the effectiveness and safety of multi-strain probiotic in a …
Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.
Baştürk A, Artan R, Yılmaz A. Baştürk A, et al. Turk J Gastroenterol. 2016 Sep;27(5):439-443. doi: 10.5152/tjg.2016.16301. Turk J Gastroenterol. 2016. PMID: 27782892 Free article. Clinical Trial.
BACKGROUND/AIMS: Irritable bowel syndrome (IBS) is an important health problem that presents serious social burdens and high costs. ...
BACKGROUND/AIMS: Irritable bowel syndrome (IBS) is an important health problem that presents serious social burdens and …
Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
Leventogiannis K, Gkolfakis P, Spithakis G, Tsatali A, Pistiki A, Sioulas A, Giamarellos-Bourboulis EJ, Triantafyllou K. Leventogiannis K, et al. Probiotics Antimicrob Proteins. 2019 Jun;11(2):627-634. doi: 10.1007/s12602-018-9401-3. Probiotics Antimicrob Proteins. 2019. PMID: 29508268 Free PMC article.
The effect of probiotics on small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome (IBS) has never been studied so far. In this prospective trial, five patients with IBS and SIBO and 21 patients with IBS without SIBO were administered an ora …
The effect of probiotics on small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome (IBS) has never be …
180 results